Key facts
- Nabla’s last known valuation is $135.6M (Jul 2024).
- It has raised $130.6M; the latest was Later Stage VC ($79.7M) in Jun 2025.
- Notable investors include DST Global, HV Capital, Firstminute Capital, Cathay Innovation, Build Collective — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Nabla
- ·The full record, as it builds
Funding rounds
No funding rounds for Nabla are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nabla
Developer of an artificial intelligence-based machine learning-powered care platform designed to identify personalized, actionable trends to improve health. The company's platform allows users to chat with practitioners, offer community content, help centralize medical data, and message health professionals, it generates clinical notes in seconds from any encounter across all specialties, reducing practitioners' stress and improving patient care, enabling healthcare firms to build engaging relationships with their patients and improve their health outcomes.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2018
- Employees
- 50
- Website
- nabla.com/
- Ownership
- Privately Held (backing)
Nabla doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nabla shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nabla in its N-PORT filings yet. We sweep new filings monthly.